...
首页> 外文期刊>Molecular medicine reports >Construction and characterization of a transmembrane eukaryotic expression vector based on the membrane domain structure of TNF-alpha
【24h】

Construction and characterization of a transmembrane eukaryotic expression vector based on the membrane domain structure of TNF-alpha

机译:基于TNF-α的膜结构域结构的跨膜真核表达载体的构建与表征

获取原文
获取原文并翻译 | 示例

摘要

The aim of the present study was to construct a fast-acting, eukaryotic expression vector in eukaryotic cells based on transmembrane-tumor necrosis factor-alpha (TM-TNF-alpha) structure. Two types of recombinant eukaryotic expression vectors were constructed, pcDNA3.1-TM-enterokinase-TNF-alpha and pcDNA3.1-TM-Factor Xa-TNF-alpha, according to the TNF-alpha transmembrane segments. Following the generation of these vectors, mouse embryonic 3T3 fibroblasts were transfected and reverse transcription-polymerase chain reaction and western blotting analyses were used to analyze mTNF-alpha mRNA and protein expression levels, respectively, in total cellular protein extracts and extracellular fluid. The biological activity of TNF-alpha in the extracellular fluid was then measured using an MTT assay. The vectors were successfully constructed, and mRNA and fusion proteins were detected in the 3T3 cells. Among the fusion proteins, the one observed in pcDNA3.1-TM-FactorXa-TNF-alpha-transfected 3T3 cells remained as a transmembrane protein. In addition, treatment of L929 cells with TNF-alpha derived extracellular fluid samples from pcDNA3.1-TM-FactorXa-TNF-alpha-transfected 3T3 cells was associated with a dose-dependent reduction in in cell-specific activity. The results indicate that proteins expressed using pcDNA3.1-TM-FactorXa-TNF-alpha vectors form transmembrane proteins. In addition, the results indicate that, only when coupled with FactorXa activity, the extracellular region of TM-TNF-alpha forms s-TNF-alpha, and the controlled expression of the fusion protein is initiated.
机译:本研究的目的是在基于跨膜 - 肿瘤坏死因子-α(TM-TNF-α)结构的真核细胞中构建快速作用的真核表达载体。根据TNF-α跨膜段,构建了两种类型的重组真核表达载体,PCDNA3.1-TM-EXENKININAS-TNF-α和PCDNA3.1-TM XA-TNF-α。在产生这些载体之后,转染小鼠胚胎3T3成纤维细胞,并逆转录 - 聚合酶链反应和蛋白质印迹分析分别用于分析总细胞蛋白提取物和细胞外液中的MTNF-αmRNA和蛋白表达水平。然后使用MTT测定测量细胞外液中TNF-α的生物活性。成功构建了载体,在3T3细胞中检测到mRNA和融合蛋白。在融合蛋白中,在PCDNA3.1-TM-FactionXA-TNF-α-Try-α-转染的3T3细胞中观察到的蛋白质仍然是跨膜蛋白。此外,使用来自PCDNA3.1-TM-FactionXA-TNF-α-转染的3T3细胞的TNF-α衍生的细胞外液样品的L929细胞与细胞特异性活性的剂量依赖性减少相关。结果表明使用PCDNA3.1-TM-FactionXA-TNF-α-TNF-α-TNF-α-TNF-α-TNF-α-TNF-α-TNF-α-TNF-α-TNF-α蛋白表达的蛋白质。另外,结果表明,仅当与因子活性结合时,开始TM-TNF-α的细胞外区域S-TNF-α,并开始融合蛋白的受控表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号